Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
554.00    0.50 (0.09%)
Bid:
554.00
Ask:
554.50
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

8 Jul 2014 10:01

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) was informed yesterday that on 7 July 2014 a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (“Shares”) was made under the Tate & Lyle 2012 Performance Share Plan (“PSP”) to an Executive Director and the Persons Discharging Managerial Responsibilities (“PDMR”) as detailed in the table below:

Name Role No. of Shares subject to option No of Shares subject to award
Javed Ahmed Executive Director 305,584 -
Robert Gibber PDMR 160,717 -
Rob Luijten PDMR 112,400 -
Olivier Rigaud PDMR 137,746 -
Gabrielle Parisse PDMR - 123,404
Matt Wineinger PDMR - 154,073

Options and awards granted under the PSP will only vest to the extent that certain performance criteria are satisfied by the Company over a three-year performance period which runs from 1 April 2014 to 31 March 2017. No consideration is payable for the grant or exercise of the options or awards.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

Lucie GilbertCompany Secretary8 July 2014

Copyright Business Wire 2014

Date   Source Headline
23rd Oct 202411:00 amRNSHolding(s) in Company
22nd Oct 20245:28 pmRNSTransaction in Own Shares
22nd Oct 202412:45 pmRNSTotal Voting Rights
21st Oct 20245:36 pmRNSTransaction in Own Shares
18th Oct 20245:46 pmRNSTransaction in Own Shares
17th Oct 20245:40 pmRNSTransaction in Own Shares
16th Oct 20245:20 pmRNSTransaction in Own Shares
15th Oct 20245:23 pmRNSTransaction in Own Shares
14th Oct 20245:29 pmRNSTransaction in Own Shares
11th Oct 20245:38 pmRNSTransaction in Own Shares
10th Oct 20245:36 pmRNSTransaction in Own Shares
9th Oct 20245:26 pmRNSTransaction in Own Shares
8th Oct 20245:32 pmRNSTransaction in Own Shares
7th Oct 20245:41 pmRNSTransaction in Own Shares
4th Oct 20245:58 pmRNSTransaction in Own Shares
3rd Oct 20245:34 pmRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSInformation - combination Tate & Lyle / CP Kelco
2nd Oct 20245:47 pmRNSTransaction in Own Shares
1st Oct 20245:32 pmRNSTransaction in Own Shares
1st Oct 202412:00 pmRNSTotal Voting Rights
30th Sep 20245:25 pmRNSTransaction in Own Shares
27th Sep 20245:49 pmRNSTransaction in Own Shares
26th Sep 20245:33 pmRNSTransaction in Own Shares
25th Sep 20245:33 pmRNSTransaction in Own Shares
24th Sep 20243:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20245:45 pmRNSTransaction in Own Shares
20th Sep 20245:40 pmRNSTransaction in Own Shares
19th Sep 20245:51 pmRNSTransaction in Own Shares
18th Sep 20245:31 pmRNSTransaction in Own Shares
17th Sep 20245:33 pmRNSTransaction in Own Shares
16th Sep 20245:40 pmRNSTransaction in Own Shares
13th Sep 20245:32 pmRNSTransaction in Own Shares
12th Sep 20245:41 pmRNSTransaction in Own Shares
11th Sep 20245:35 pmRNSTransaction in Own Shares
10th Sep 20245:42 pmRNSTransaction in Own Shares
9th Sep 20245:27 pmRNSTransaction in Own Shares
9th Sep 202411:00 amRNSHolding(s) in Company
6th Sep 20245:47 pmRNSTransaction in Own Shares
5th Sep 20245:47 pmRNSTransaction in Own Shares
5th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:58 pmRNSTransaction in Own Shares
3rd Sep 20245:33 pmRNSTransaction in Own Shares
2nd Sep 20245:44 pmRNSTransaction in Own Shares
2nd Sep 20245:00 pmRNSTotal Voting Rights
30th Aug 20245:39 pmRNSTransaction in Own Shares
29th Aug 20245:26 pmRNSTransaction in Own Shares
28th Aug 20245:27 pmRNSTransaction in Own Shares
27th Aug 20245:34 pmRNSTransaction in Own Shares
23rd Aug 20245:49 pmRNSTransaction in Own Shares
22nd Aug 20245:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.